Abbott India (ABBOTINDIA)
SLOW GROWERFairStock Score: 63/100 — STEADY
Score breakdown: P/E: 0/3 · ROCE: 2/2 · Growth: 1/2 · Dividend: 0/1
Key Financials
| Current Price | ₹25,422.5 |
| Market Cap | ₹56,376.25 Cr |
| P/E Ratio | 36.99 |
| ROCE | 46.25% |
| ROE | 36% |
| Dividend Yield | 1.79% |
| Profit Growth | 14.21% |
| Debt/Equity | 0.05 |
| Sales Growth | 9.31% |
| Free Cash Flow | ₹1,19,402 Cr |
| Promoter Holding | 74.99% |
| 52-Week Range | ₹25,150 — ₹37,000 |
| Sector | Pharmaceuticals & Biotechnology |
| Book Value | ₹1,992.07 |
Abbott India trades with a P/E ratio of 36.99, ROCE of 46.25%, ROE of 36%, profit growth of 14.21%, debt-to-equity of 0.05. The FairStock Score of 63/100 suggests mixed fundamentals — some metrics look solid while others need improvement.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer